Exploiting host immunity: The Salmonella paradigm

Trends in Immunology

Volumn 36, Issue 2, 2015, Pages 112-120

  Behnsen, Judith ^a   Perez Lopez, Araceli ^a   Nuccio, Sean Paul ^a   Raffatellu, Manuela ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Immune evasion; Immunity; Inflammation; Mucosal immunity; Salmonella

Indexed keywords

ANTIINFECTIVE AGENT; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN METABOLITE; TOLL LIKE RECEPTOR;

BACTERIAL IMMUNITY; BACTERIAL VIRULENCE; CELL DEATH; GASTROINTESTINAL INFECTION; HOST CELL; IMMUNE EVASION; IMMUNE RESPONSE; INNATE IMMUNITY; INTESTINE FLORA; INTESTINE INFECTION; MACROPHAGE; NONHUMAN; REVIEW; SALMONELLA; SALMONELLOSIS; ANIMAL; HOST PATHOGEN INTERACTION; HUMAN; IMMUNITY; IMMUNOLOGY; INTESTINE; METABOLISM; MICROBIOLOGY; OXIDATIVE STRESS;

ANIMALS; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNITY; INTESTINES; OXIDATIVE STRESS; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN SPECIES; SALMONELLA; SALMONELLA INFECTIONS; TOLL-LIKE RECEPTORS;

EID: 84922117247     PISSN: 14714906     EISSN: 14714981     Source Type: Journal    
DOI: 10.1016/j.it.2014.12.003     Document Type: Review

References (80)

1. Majowicz S.E., et al. The global burden of nontyphoidal Salmonella gastroenteritis. Clin. Infect. Dis. 2010, 50:882-889.
2. Crump J.A., et al. The global burden of typhoid fever. Bull. World Health Organ. 2004, 82:346-353.
3. Nuccio S.P., Bäumler A.J. Comparative analysis of Salmonella genomes identifies a metabolic network for escalating growth in the inflamed gut. MBio 2014, 5:1-10.
4. Gal-Mor O., et al. Same species, different diseases: how and why typhoidal and non-typhoidal Salmonella enterica serovars differ. Front. Microbiol. 2014, 5:391. 10.3389/fmicb.2014.00391.
5. Haraga A., et al. Salmonellae interplay with host cells. Nat. Rev. Microbiol. 2008, 6:53-66.
6. Lupp C., et al. Host-mediated inflammation disrupts the intestinal microbiota and promotes the overgrowth of Enterobacteriaceae. Cell Host Microbe 2007, 2:204.
7. Stecher B., et al. Salmonella enterica serovar typhimurium exploits inflammation to compete with the intestinal microbiota. PLoS Biol. 2007, 5:2177-2189.
8. Lawley T.D., et al. Host transmission of Salmonella enterica serovar Typhimurium is controlled by virulence factors and indigenous intestinal microbiota. Infect. Immun. 2008, 76:403-416.
9. Liu J.Z., et al. Zinc sequestration by the neutrophil protein calprotectin enhances Salmonella growth in the inflamed gut. Cell Host Microbe 2012, 11:227-239.
10. Behnsen J., et al. The cytokine IL-22 promotes pathogen colonization by suppressing related commensal bacteria. Immunity 2014, 40:262-273.
11. Winter S.E., et al. Gut inflammation provides a respiratory electron acceptor for Salmonella. Nature 2010, 467:426-429.
12. Raffatellu M., et al. Lipocalin-2 resistance confers an advantage to Salmonella enterica serotype Typhimurium for growth and survival in the inflamed intestine. Cell Host Microbe 2009, 5:476-486.
13. Nuccio S.P., et al. Typhoid. The Prokaryotes 2013, 375-399. Springer. E. Rosenberg (Ed.).
14. Benoit M., et al. Macrophage polarization in bacterial infections. J. Immunol. 2008, 181:3733-3739.
15. Weiss D.S., et al. Toll-like receptors are temporally involved in host defense. J. Immunol. 2004, 172:4463-4469.
16. Wong C.E., et al. Salmonella enterica serovar typhimurium exploits Toll-like receptor signaling during the host-pathogen interaction. Infect. Immun. 2009, 77:4750-4760.
17. Arpaia N., et al. TLR signaling is required for Salmonella typhimurium virulence. Cell 2011, 144:675-688.
18. Tabeta K., et al. The Unc93b1 mutation 3d disrupts exogenous antigen presentation and signaling via Toll-like receptors 3, 7 and 9. Nat. Immunol. 2006, 7:156-164.
19. Sivick K.E., et al. Toll-like receptor-deficient mice reveal how innate immune signaling influences Salmonella virulence strategies. Cell Host Microbe 2014, 15:203-213.
20. Franchi L., et al. Cytosolic flagellin requires Ipaf for activation of caspase-1 and interleukin 1beta in Salmonella-infected macrophages. Nat. Immunol. 2006, 7:576-582.
21. Miao E.A., et al. Cytoplasmic flagellin activates caspase-1 and secretion of interleukin 1beta via Ipaf. Nat. Immunol. 2006, 7:569-575.
22. Broz P., et al. Redundant roles for inflammasome receptors NLRP3 and NLRC4 in host defense against Salmonella. J. Exp. Med. 2010, 207:1745-1755.
23. Bergsbaken T., et al. Pyroptosis: host cell death and inflammation. Nat. Rev. Microbiol. 2009, 7:99-109.
24. + efflux is the common trigger of NLRP3 inflammasome activation by bacterial toxins and particulate matter. Immunity 2013, 38:1142-1153.
25. + T cell responses are restricted by bacterial regulation of antigen expression. J. Immunol. 2005, 174:7929-7938.
26. Wynosky-Dolfi M.A., et al. Oxidative metabolism enables Salmonella evasion of the NLRP3 inflammasome. J. Exp. Med. 2014, 211:653-668.
27. Zaki M.H., et al. Salmonella exploits NLRP12-dependent innate immune signaling to suppress host defenses during infection. Proc. Natl. Acad. Sci. U.S.A. 2013, 111:385-390.
28. Anand P.K., et al. NLRP6 negatively regulates innate immunity and host defence against bacterial pathogens. Nature 2012, 488:389-393.
29. Miao E.A., et al. Caspase-1-induced pyroptosis is an innate immune effector mechanism against intracellular bacteria. Nat. Immunol. 2010, 11:1136-1142.
30. Broz P., et al. Caspase-11 increases susceptibility to Salmonella infection in the absence of caspase-1. Nature 2012, 490:288-291.
31. Kayagaki N., et al. Noncanonical inflammasome activation by intracellular LPS independent of TLR4. Science 2013, 341:1246-1249.
32. Hagar J.A., et al. Cytoplasmic LPS activates caspase-11: implications in TLR4-independent endotoxic shock. Science 2013, 341:1250-1253.
33. Knodler L.A., et al. Dissemination of invasive Salmonella via bacterial-induced extrusion of mucosal epithelia. Proc. Natl. Acad. Sci. U.S.A. 2010, 107:17733-17738.
34. Humphries F., et al. RIP kinases: key decision makers in cell death and innate immunity. Cell Death Differ. 2014, Published online August 22, 2014. http://dx.doi.org/10.1038/cdd.2014.126.
35. Robinson N., et al. Type I interferon induces necroptosis in macrophages during infection with Salmonella enterica serovar Typhimurium. Nat. Immunol. 2012, 13:954-962.
36. Eisele N.A., et al. Salmonella require the fatty acid regulator PPARdelta for the establishment of a metabolic environment essential for long-term persistence. Cell Host Microbe 2013, 14:171-182.
37. McCoy M.W., et al. Hemophagocytic macrophages in murine typhoid fever have an anti-inflammatory phenotype. Infect. Immun. 2012, 80:3642-3649.
38. Nix R.N., et al. Hemophagocytic macrophages harbor Salmonella enterica during persistent infection. PLoS Pathog. 2007, 3:e193.
39. Grygiel-Gorniak B. Peroxisome proliferator-activated receptors and their ligands: nutritional and clinical implications - a review. Nutr. J. 2014, 13:17.
40. Berger J., Moller D.E. The mechanisms of action of PPARs. Annu. Rev. Med. 2002, 53:409-435.
41. Kullas A.L., et al. L-asparaginase II produced by Salmonella typhimurium inhibits T cell responses and mediates virulence. Cell Host Microbe 2012, 12:791-798.
42. Godinez I., et al. Interleukin-23 orchestrates mucosal responses to Salmonella enterica serotype Typhimurium in the intestine. Infect. Immun. 2009, 77:387-398.
43. O'Donnell H., et al. Toll-like receptor and inflammasome signals converge to amplify the innate bactericidal capacity of T helper 1 cells. Immunity 2014, 40:213-224.
44. Raffatellu M., et al. Simian immunodeficiency virus-induced mucosal interleukin-17 deficiency promotes Salmonella dissemination from the gut. Nat. Med. 2008, 14:421-428.
45. Godinez I., et al. T cells help to amplify inflammatory responses induced by Salmonella enterica serotype Typhimurium in the intestinal mucosa. Infect. Immun. 2008, 76:2008-2017.
46. Takatori H., et al. Lymphoid tissue inducer-like cells are an innate source of IL-17 and IL-22. J. Exp. Med. 2009, 206:35-41.
47. Zindl C.L., et al. IL-22-producing neutrophils contribute to antimicrobial defense and restitution of colonic epithelial integrity during colitis. Proc. Natl. Acad. Sci. U.S.A. 2013, 110:12768-12773.
48. Sutton C.E., et al. Interleukin-1 and IL-23 induce innate IL-17 production from gammadelta T cells, amplifying Th17 responses and autoimmunity. Immunity 2009, 31:331-341.
49. Geddes K., et al. Identification of an innate T helper type 17 response to intestinal bacterial pathogens. Nat. Med. 2011, 17:837-844.
50. Ouyang W., et al. The biological functions of T helper 17 cell effector cytokines in inflammation. Immunity 2008, 28:454-467.
51. Kundu P., et al. Absence of intestinal PPARgamma aggravates acute infectious colitis in mice through a lipocalin-2-dependent pathway. PLoS Pathog. 2014, 10:e1003887.
52. Liu J.Z., et al. Th17 cytokines and host-pathogen interactions at the mucosa: dichotomies of help and harm. Cytokine 2009, 48:156-160.
53. Goetz D.H., et al. The neutrophil lipocalin NGAL is a bacteriostatic agent that interferes with siderophore-mediated iron acquisition. Mol. Cell 2002, 10:1033-1043.
54. Flo T.H., et al. Lipocalin 2 mediates an innate immune response to bacterial infection by sequestrating iron. Nature 2004, 432:917-921.
55. Corbin B.D., et al. Metal chelation and inhibition of bacterial growth in tissue abscesses. Science 2008, 319:962-965.
56. Urban C.F., et al. Neutrophil extracellular traps contain calprotectin, a cytosolic protein complex involved in host defense against Candida albicans. PLoS Pathog. 2009, 5:e1000639.
57. Kobayashi Y. The regulatory role of nitric oxide in proinflammatory cytokine expression during the induction and resolution of inflammation. J. Leukoc. Biol. 2010, 88:1157-1162.
58. Zhang Y., et al. IL-17A synergizes with IFN-gamma to upregulate iNOS and NO production and inhibit chlamydial growth. PLoS ONE 2012, 7:e39214.
59. Fang F.C. Antimicrobial actions of reactive oxygen species. MBio 2011, 2. e00141-11.
60. Henard C.A., Vazquez-Torres A. Nitric oxide and Salmonella pathogenesis. Front. Microbiol. 2011, 2:84.
61. Holland S.M. Chronic granulomatous disease. Clin. Rev. Allergy Immunol. 2010, 38:3-10.
62. Felmy B., et al. NADPH oxidase deficient mice develop colitis and bacteremia upon infection with normally avirulent, TTSS-1- and TTSS-2-deficient Salmonella Typhimurium. PLoS ONE 2013, 8:e77204.
63. Alam M.S., et al. Nitric oxide produced in Peyer's patches exhibits antiapoptotic activity contributing to an antimicrobial effect in murine salmonellosis. Microbiol. Immunol. 2008, 52:197-208.
64. Ackermann M., et al. Self-destructive cooperation mediated by phenotypic noise. Nature 2008, 454:987-990.
65. Burton N.A., et al. Disparate impact of oxidative host defenses determines the fate of Salmonella during systemic infection in mice. Cell Host Microbe 2014, 15:72-83.
66. Bogomolnaya L.M., et al. The ABC-type efflux pump MacAB protects Salmonella enterica serovar typhimurium from oxidative stress. MBio 2013, 4. e00630-13.
67. De Groote M.A., et al. Periplasmic superoxide dismutase protects Salmonella from products of phagocyte NADPH-oxidase and nitric oxide synthase. Proc. Natl. Acad. Sci. U.S.A. 1997, 94:13997-14001.
68. Henard C.A., Vazquez-Torres A. DksA-dependent resistance of Salmonella enterica serovar Typhimurium against the antimicrobial activity of inducible nitric oxide synthase. Infect. Immun. 2012, 80:1373-1380.
69. Husain M., et al. Ferric uptake regulator-dependent antinitrosative defenses in Salmonella enterica serovar Typhimurium pathogenesis. Infect. Immun. 2014, 82:333-340.
70. Thiennimitr P., et al. Intestinal inflammation allows Salmonella to use ethanolamine to compete with the microbiota. Proc. Natl. Acad. Sci. U.S.A. 2011, 108:17480-17485.
71. Lopez C.A., et al. Phage-mediated acquisition of a type III secreted effector protein boosts growth of Salmonella by nitrate respiration. MBio 2012, 3:e00143-e212.
72. Rivera-Chavez F., et al. Salmonella uses energy taxis to benefit from intestinal inflammation. PLoS Pathog. 2013, 9:e1003267.
73. Spees A.M., et al. Colonization resistance: battle of the bugs or Ménage à Trois with the host?. PLoS Pathog. 2013, 9:e1003730.
74. Lawhon S.D., et al. Intestinal short-chain fatty acids alter Salmonella typhimurium invasion gene expression and virulence through BarA/SirA. Mol. Microbiol. 2002, 46:1451-1464.
75. Deriu E., et al. Probiotic bacteria reduce Salmonella typhimurium intestinal colonization by competing for iron. Cell Host Microbe 2013, 14:26-37.
76. Lamichhane-Khadka R., et al. The Hyb hydrogenase permits hydrogen-dependent respiratory growth of Salmonella enterica serovar Typhimurium. MBio 2010, 1.
77. Maier L., et al. Microbiota-derived hydrogen fuels Salmonella typhimurium invasion of the gut ecosystem. Cell Host Microbe 2013, 14:641-651.
78. Ng K.M., et al. Microbiota-liberated host sugars facilitate post-antibiotic expansion of enteric pathogens. Nature 2013, 502:96-99.
79. Stentz R., et al. Cephalosporinases associated with outer membrane vesicles released by Bacteroides spp. protect gut pathogens and commensals against beta-lactam antibiotics. J. Antimicrob. Chemother. 2014, Published online November 27, 2014. http://dx.doi.org/10.1093/jac/dku466.
80. Ganesh B.P., et al. Commensal Akkermansia muciniphila exacerbates gut inflammation in Salmonella Typhimurium-infected gnotobiotic mice. PLoS ONE 2013, 8:e74963.